In a recent study posted to the medRxiv* preprint server, researchers developed a personalized therapy selection algorithm for two diabetes type 2 (T2D) treatment drug classes, i.e., sodium-glucose cotransporter 2 (SGLT2)-inhibitors (SGLT2i, reference class) and glucagon-like peptide-1 (GLP1)-receptor agonist (GLP1-RA) medications
The most common ingredients youll find are alpha-GPC, citicoline, and huperzine A, but you might also find DMAE, donepezil, and galantamine
This applies to both male and female research subjects
This suggests that IL-17A may affect airway and parenchymal mechanics through partially independent pathways
Of note, the higher vulnerability of women than men to develop mood disorders begins about at the onset of puberty with the beginning of reproductive life [15, 16]